Clinical trial
Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related…
NCT00183976 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00183976 |
|---|---|
| Title | Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas |
| Official title | A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas |
| Lead sponsor | University of Southern California, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Burkitt Lymphoma, Primary Effusion Lymphomas |
| Intervention type | Drug |
| Interventions | Pegylated Liposomal Doxorubicin (Doxil) and Rituximab |
| Enrollment | 15 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: